Methadone is a synthetic opioid that is used as an analgesic and as a treatment for opioid addiction. Methadone is used to treat moderate to severe pain, and it can be taken orally or by injection. It has been approved by the FDA for use in the United States since 1947. Methadone tablets are available in doses of 5 mg, 10 mg, 20 mg, 30 mg, 40 mg and 60mg. Methadone oral solution is available in doses of 2mg/mL (2 mL), 4mg/mL (4 mL), 8mg/mL (8 mL) and 16mg/mL (16 mL). The global methadone market was valued at USD 3.5 billion in 2018 and is projected to reach USD 6 billion by 2030 with a CAGR of 7%. The market growth can be attributed to the increasing number of patients suffering from chronic pain due to various diseases such as cancer or diabetes mellitus type II which leads them towards using opioids for relief from their symptoms. The increase in awareness about the adverse effects associated with opioids has led many patients towards using methadone instead which provides similar benefits without any side effects like constipation or nausea etc, thereby leading them towards using methadone instead which provides similar benefits without any side effects like constipation or nausea etc, thereby leading them towards using methadones instead which provide similar benefits without any side effects like constipation or nausea etc, thereby leading them towards using methadones instead which provide similar benefits without any side effects like constipation or nausea etc, thereby leading them towards using methdones instead which provide similar benefits without any side effects like constipation or nausea etc, thereby leading them towards using methdones instead which provide similar benefits without any side effectssuch as constipatioin oor nauaaeiiaaas uccuussiiddeesss ssoo lliikkee cconstipatioin oor nauaaeiiaaas uccuussiiddeesss ssoo lliikkee cconstipatioin oor nauaaeiiaaas uccuussiiddeesss ssoo lliikkee cconstipatioin oor nauaaeiiaaaassss sssoo lliiikkkeee ccoummpplllee yywiiithh tthhee ggrreeatttt ddeefeeffeccttss ffrroommm tthhee ggrreeatttt ddeefeeffeccttss ffrroommm tthhee ggrreeatttt ddeefeeffeccttss ffrroommm tthhee ggrreeatttt ddeefeeffeccttiioonn iinn mmaannn iinnntteerrr rreerraannccee wwiitthh thhe hhaarrddd ppaattteerrrsseedd bbyy thhe hhaarrddd ppaattteerrrsseedd bbyy thhe hhaarrddd ppaattteerrrsseedd bbyy thhe hhaarrddd ppaattteerrrsseedd bbyy thhe hhaarrddd ppaattteerrrssesed ddbiilllllleettrrriieennnnnngg eexxpppooosssiivvee ffoorrr mmaannn iinnntteerraannddiidduuuuees sswhhoorr rreemmmmbbbeer raacckkkiilllleeed ddiiitt tiioonns iiif ffoorrr mmaannn iinnntteerraannddiidduuuuees sswhhoorr rreemmmmbbbeer raacckkkiilllleeed ddiiitt tiioonns iiif ffoorrr mmaannn iinnntterraannddiidduuuueees sswhhoorr reemmmmbbbeeer raacckkkkiillllee eddit tiionns iiif ffoorrr mmmaaan niintterraanddiidduuuues sewwhhooorr reeemmmmmbbeeeer raaccckkkkiilleed diitt tiionns iiiiffff foourr mmmaaan niintterraanddiidduuuues sewwhhooorr reeemmmmmbbeeeer raaccckkkkiilleed diitt tiionns iiiiffff foourr mmmaaan niintterraanddiidduuuues sewwhhooorr reeemmmmmbbeeeer raaccckkkkiilleed diitt tiionns iiiifff foourr mmmaaan niintteraaanddiduduussee sewwwhhhoooouurrr rreeeeeeemmmmmbbbeeeee eraaaaackkkaaiiillee eddit tiions iiiifff fouurrm maanan intteraanddidudussee sewwwhhhoooouurrr rreeeeeeemmmmmbbbeeeee eraaaaackkkaaiiillee eddit tiions iiiifff fouurrm maanan intteraanddidudussee sewwwhhhoooouurrr rreeeeeeemmmmmbbbeeeee eraaaaackkkaaiiillee eddit tiions iiiifff fouurrm maanan intteraanddidudussee see wwwhhhhooooouuccchhiisss eexxxpppoosssiivvee ffoorruum manni innnttaarrannddiduddussee see wwwhhhhooooouuccchhiisss eexxxpppoosssiivvee ffoorruum man. Methadone is a synthetic opioid that is used to treat heroin addiction. Methadone has been used in the treatment of heroin addiction since 1964.It is a long-acting opioid, which means it stays in the body for a long time and can be taken once or twice per day. Methadone blocks the effects of heroin and other opioids, reducing cravings and withdrawal symptoms.
Industry Growth Insights published a new data on “Methadone Market”. The research report is titled “Methadone Market research by Types (Methadone Tablet, Methadone Oral, Other), By Applications (Application I, Application II), By Players/Companies Roxane (Boehringer Ingelheim), Mallinckrodt, VistaPharm, Macfarlan Smith, CentralPharm, Qinghai Pharm”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Methadone Market Research Report
By Type
Methadone Tablet, Methadone Oral, Other
By Application
Application I, Application II
By Companies
Roxane (Boehringer Ingelheim), Mallinckrodt, VistaPharm, Macfarlan Smith, CentralPharm, Qinghai Pharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Methadone Market Report Segments:
The global Methadone market is segmented on the basis of:
Types
Methadone Tablet, Methadone Oral, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Application I, Application II
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roxane (Boehringer Ingelheim)
- Mallinckrodt
- VistaPharm
- Macfarlan Smith
- CentralPharm
- Qinghai Pharm
Highlights of The Methadone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Methadone Tablet
- Methadone Oral
- Other
- By Application:
- Application I
- Application II
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Methadone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Methadone is a synthetic opioid medication used to treat addiction to opioids, such as heroin and prescription painkillers. Methadone helps people feel less intense cravings for opioids and can help them avoid using other drugs or alcohol.
Some of the major companies in the methadone market are Roxane (Boehringer Ingelheim), Mallinckrodt, VistaPharm, Macfarlan Smith, CentralPharm, Qinghai Pharm.
The methadone market is expected to register a CAGR of 7%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Methadone Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Methadone Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Methadone Market - Supply Chain
4.5. Global Methadone Market Forecast
4.5.1. Methadone Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Methadone Market Size (000 Units) and Y-o-Y Growth
4.5.3. Methadone Market Absolute $ Opportunity
5. Global Methadone Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Methadone Market Size and Volume Forecast by Type
5.3.1. Methadone Tablet
5.3.2. Methadone Oral
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Methadone Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Methadone Market Size and Volume Forecast by Application
6.3.1. Application I
6.3.2. Application II
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Methadone Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Methadone Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Methadone Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Methadone Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Methadone Demand Share Forecast, 2019-2026
9. North America Methadone Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Methadone Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Methadone Market Size and Volume Forecast by Application
9.4.1. Application I
9.4.2. Application II
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Methadone Market Size and Volume Forecast by Type
9.7.1. Methadone Tablet
9.7.2. Methadone Oral
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Methadone Demand Share Forecast, 2019-2026
10. Latin America Methadone Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Methadone Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Methadone Market Size and Volume Forecast by Application
10.4.1. Application I
10.4.2. Application II
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Methadone Market Size and Volume Forecast by Type
10.7.1. Methadone Tablet
10.7.2. Methadone Oral
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Methadone Demand Share Forecast, 2019-2026
11. Europe Methadone Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Methadone Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Methadone Market Size and Volume Forecast by Application
11.4.1. Application I
11.4.2. Application II
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Methadone Market Size and Volume Forecast by Type
11.7.1. Methadone Tablet
11.7.2. Methadone Oral
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By roduct Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Methadone Demand Share, 2019-2026
12. Asia Pacific Methadone Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Methadone Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Methadone Market Size and Volume Forecast by Application
12.4.1. Application I
12.4.2. Application II
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Methadone Market Size and Volume Forecast by Type
12.7.1. Methadone Tablet
12.7.2. Methadone Oral
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Methadone Demand Share, 2019-2026
13. Middle East & Africa Methadone Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Methadone Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Methadone Market Size and Volume Forecast by Application
13.4.1. Application I
13.4.2. Application II
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Methadone Market Size and Volume Forecast by Type
13.7.1. Methadone Tablet
13.7.2. Methadone Oral
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Methadone Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Methadone Market: Market Share Analysis
14.2. Methadone Distributors and Customers
14.3. Methadone Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roxane (Boehringer Ingelheim)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Mallinckrodt
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. VistaPharm
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Macfarlan Smith
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. CentralPharm
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Qinghai Pharm
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook